Targeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary Fibrosis
Top Cited Papers
- 1 February 2010
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 181 (3), 254-263
- https://doi.org/10.1164/rccm.200810-1615oc
Abstract
Ineffective repair of a damaged alveolar epithelium has been postulated to cause pulmonary fibrosis. In support of this theory, epithelial cell abnormalities, including hyperplasia, apoptosis, and persistent denudation of the alveolar basement membrane, are found in the lungs of humans with idiopathic pulmonary fibrosis and in animal models of fibrotic lung disease. Furthermore, mutations in genes that affect regenerative capacity or that cause injury/apoptosis of type II alveolar epithelial cells have been identified in familial forms of pulmonary fibrosis. Although these findings are compelling, there are no studies that demonstrate a direct role for the alveolar epithelium or, more specifically, type II cells in the scarring process. To determine if a targeted injury to type II cells would result in pulmonary fibrosis. A transgenic mouse was generated to express the human diphtheria toxin receptor on type II alveolar epithelial cells. Diphtheria toxin was administered to these animals to specifically target the type II epithelium for injury. Lung fibrosis was assessed by histology and hydroxyproline measurement. Transgenic mice treated with diphtheria toxin developed an approximately twofold increase in their lung hydroxyproline content on Days 21 and 28 after diphtheria toxin treatment. The fibrosis developed in conjunction with type II cell injury. Histological evaluation revealed diffuse collagen deposition with patchy areas of more confluent scarring and associated alveolar contraction. The development of lung fibrosis in the setting of type II cell injury in our model provides evidence for a causal link between the epithelial defects seen in idiopathic pulmonary fibrosis and the corresponding areas of scarring.Keywords
This publication has 38 references indexed in Scilit:
- Adult-onset pulmonary fibrosis caused by mutations in telomeraseProceedings of the National Academy of Sciences of the United States of America, 2007
- Monocyte/Macrophage Suppression in CD11b Diphtheria Toxin Receptor Transgenic Mice Differentially Affects Atherogenesis and Established PlaquesCirculation Research, 2007
- Telomerase Mutations in Families with Idiopathic Pulmonary FibrosisThe New England Journal of Medicine, 2007
- A Diphtheria Toxin Receptor Deficient in Epidermal Growth Factor–Like Biological ActivityThe Journal of Biochemistry, 2006
- Role of Epithelial Cells in Idiopathic Pulmonary Fibrosis: From Innocent Targets to Serial KillersProceedings of the American Thoracic Society, 2006
- Diphtheria Toxin-induced Autophagic Cardiomyocyte Death Plays a Pathogenic Role in Mouse Model of Heart FailureOnline Journal of Public Health Informatics, 2004
- In Vivo Depletion of CD11c+ Dendritic Cells Abrogates Priming of CD8+ T Cells by Exogenous Cell-Associated AntigensImmunity, 2002
- Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursorCell, 1992
- Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators.JCI Insight, 1986
- Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production.JCI Insight, 1980